Experiences with a centralised national service for autologous serum eyedrops in England

S Maclennan, D Hartwig, G Geerling - Der Ophthalmologe, 2008 - Springer
S Maclennan, D Hartwig, G Geerling
Der Ophthalmologe, 2008Springer
The majority of patients with dry eye syndromes respond to conventional treatment aimed at
optimising the ocular surface environment. There are some, however, who do not respond
adequately to conventional lubricants. The first description of the use of autologous serum
as a nutrient tears substitute was published more than 20 years ago. In 1997, NHS Blood
and Transplant (NHSBT) developed a reliable and reproducible method for the production of
eyedrops derived from autologous serum according to GMP Guidelines. The current cost of …
Abstract
The majority of patients with dry eye syndromes respond to conventional treatment aimed at optimising the ocular surface environment. There are some, however, who do not respond adequately to conventional lubricants. The first description of the use of autologous serum as a nutrient tears substitute was published more than 20 years ago. In 1997, NHS Blood and Transplant (NHSBT) developed a reliable and reproducible method for the production of eyedrops derived from autologous serum according to GMP Guidelines. The current cost of a batch of eyedrops (i. e. the product from one donation episode) is approximately 1300 GBP – this covers costs of collection, processing, testing and distribution. One “batch” of eyedrops will last for approximately 5 months if a bottle a day is used. A 6 month shelf life is put on the product and patients keep them in their domestic freezer.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果